EDTA anticoagulated peripheral blood as flow cytometry samples was drawn from the participants before initial treatment to determine lymphocyte and subsets. All samples were tested within 6 hours of being obtained. Briefly, CD3+/CD4+/CD8+ T-cell, CD19+ B-cell, and CD16+ CD56+ NK-cell counts (cells/μL) were measured by multiple-color flow cytometry with human monoclonal anti-CD3-fluorescein isothiocyanate (FITC), anti-CD4-phycoerythrin (PE), antiCD8-allophycocyanin (APC), anti-CD19-PE, and anti-CD56-PE antibodies (BD Multitest) according to the manufacturer’s instructions. The cells were analyzed on a BD FACS Canto II flow cytometry system (BD Biosciences) (15 (link), 19 (link)).
Free full text: Click here